Idenix Pharma initiated with "outperform"

10/21/09 - Wedbush Morgan Securities

NEW YORK, October 21 (newratings.com) - Analysts at Wedbush Morgan initiate coverage of Idenix Pharma (IDEX) with an "outperform" rating. The target price is set to $5.